(Bloomberg) One of Europe’s most volatile and priciest stocks is attracting more interest from hedge funds than ever before. The company in question is Ambu A/S, which is based in Denmark and makes single-use endoscopes. Short bets against it have jumped to a record. But at the same time, analyst price estimates show the stock could surge about 45 percent this year. So, who’s right?